1. Bozkurt O, Firat ST, Dogan E, Cosar R, Inanc M, Ozkan M. The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: A retrospective study. Journal of BUON : official journal of the Balkan Union of Oncology. 2019 Sep-Oct;24(5):1992-9. PubMed PMID: 31786866.
2. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer management and research. 2018;10:239-48. PubMed PMID: 29445300. Pubmed Central PMCID: 5808709.
3. Baba H, Kuwabara K, Ishiguro T, Kumamoto K, Kumagai Y, Ishibashi K, et al. Prognostic factors for stage IV gastric cancer. International surgery. 2013 Apr-Jun;98(2):181-7. PubMed PMID: 23701157. Pubmed Central PMCID: 3723175.
4. Zhou Q, Lan X, Li N, Yuan D, Zhang J. Analysis of Prognostic Factors and Design of Prognosis Model for Patients with Stage IV Gastric Cancer Following First-Line Palliative Chemotherapy. Cancer management and research. 2020;12:10461-8. PubMed PMID: 33122945. Pubmed Central PMCID: 7588669.
5. Hirokawa N, Tanaka Y. Kinesin superfamily proteins (KIFs): Various functions and their relevance for important phenomena in life and diseases. Experimental cell research. 2015 May 15;334(1):16-25. PubMed PMID: 25724902.
6. Hirokawa N, Noda Y. Intracellular transport and kinesin superfamily proteins, KIFs: structure, function, and dynamics. Physiological reviews. 2008 Jul;88(3):1089-118. PubMed PMID: 18626067.
7. Hirokawa N, Noda Y, Tanaka Y, Niwa S. Kinesin superfamily motor proteins and intracellular transport. Nature reviews Molecular cell biology. 2009 Oct;10(10):682-96. PubMed PMID: 19773780.
8. Myers SM, Collins I. Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy. Future medicinal chemistry. 2016;8(4):463-89. PubMed PMID: 26976726. Pubmed Central PMCID: 4896392.
9. Liu X, Gong H, Huang K. Oncogenic role of kinesin proteins and targeting kinesin therapy. Cancer science. 2013 Jun;104(6):651-6. PubMed PMID: 23438337. Pubmed Central PMCID: 7657121.
10. Liu Y, Zhan P, Zhou Z, Xing Z, Zhu S, Ma C, et al. The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer. Journal of thoracic disease. 2016 Oct;8(10):2911-23. PubMed PMID: 27867568. Pubmed Central PMCID: 5107536.
11. Muhia M, Thies E, Labonte D, Ghiretti AE, Gromova KV, Xompero F, et al. The Kinesin KIF21B Regulates Microtubule Dynamics and Is Essential for Neuronal Morphology, Synapse Function, and Learning and Memory. Cell reports. 2016 May 3;15(5):968-77. PubMed PMID: 27117409. Pubmed Central PMCID: 5305027.
12. Kreft KL, van Meurs M, Wierenga-Wolf AF, Melief MJ, van Strien ME, Hol EM, et al. Abundant kif21b is associated with accelerated progression in neurodegenerative diseases. Acta neuropathologica communications. 2014 Oct 3;2:144. PubMed PMID: 25274010. Pubmed Central PMCID: PMC4207309. Epub 2014/10/03. eng.
13. Hares K, Miners JS, Cook AJ, Rice C, Scolding N, Love S, et al. Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer's Disease. Journal of Alzheimer's disease : JAD. 2017;60(4):1511-24. PubMed PMID: 29060936.
14. Gromova KV, Muhia M, Rothammer N, Gee CE, Thies E, Schaefer I, et al. Neurobeachin and the Kinesin KIF21B Are Critical for Endocytic Recycling of NMDA Receptors and Regulate Social Behavior. Cell reports. 2018 May 29;23(9):2705-17. PubMed PMID: 29847800. Epub 2018/05/31. eng.
15. Zhao HQ, Dong BL, Zhang M, Dong XH, He Y, Chen SY, et al. Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma. World journal of gastrointestinal oncology. 2020 Mar 15;12(3):276-88. PubMed PMID: 32206178. Pubmed Central PMCID: PMC7081114. Epub 2020/03/25. eng.
16. Sun ZG, Pan F, Shao JB, Yan QQ, Lu L, Zhang N. Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer. Cancer cell international. 2020;20:233. PubMed PMID: 32536821. Pubmed Central PMCID: PMC7291654. Epub 2020/06/17. eng.
17. Kunej T, Godnic I, Ferdin J, Horvat S, Dovc P, Calin GA. Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutation research. 2011 Dec 1;717(1-2):77-84. PubMed PMID: 21420983.
18. Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, et al. Role of miRNAs in immune responses and immunotherapy in cancer. Genes, chromosomes & cancer. 2019 Apr;58(4):244-53. PubMed PMID: 30578699. Pubmed Central PMCID: 6368474.
19. Jia XN, Yin SD, Wei Y, Chen L. MiR-182-5p inhibited proliferation and migration of ovarian cancer cells by targeting BNIP3. European review for medical and pharmacological sciences. 2020 Aug;24(15):7912. PubMed PMID: 32767306.
20. Wang L, Wang Y, Du X, Yao Y, Wang L, Jia Y. MiR-216b suppresses cell proliferation, migration, invasion, and epithelial-mesenchymal transition by regulating FOXM1 expression in human non-small cell lung cancer. OncoTargets and therapy. 2019;12:2999-3009. PubMed PMID: 31114243. Pubmed Central PMCID: 6489682.
21. Li S, Xu JJ, Zhang QY. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer. Cancer science. 2019 Oct;110(10):3098-109. PubMed PMID: 31389121. Pubmed Central PMCID: 6778625.
22. Wu B, Li J, Wang H, Wu Q, Liu H. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11. Naunyn-Schmiedeberg's archives of pharmacology. 2020 Nov;393(11):2197-208. PubMed PMID: 32040593. Epub 2020/02/11. eng.
23. He X, Ma J, Zhang M, Cui J, Yang H. Long Non-Coding RNA SNHG16 Activates USP22 Expression to Promote Colorectal Cancer Progression by Sponging miR-132-3p. OncoTargets and therapy. 2020;13:4283-94. PubMed PMID: 32547062. Pubmed Central PMCID: PMC7244243. Epub 2020/06/18. eng.
24. Zhang M, Li Y, Wang H, Yu W, Lin S, Guo J. LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5. Cancer biology & therapy. 2019;20(4):524-36. PubMed PMID: 30395767. Pubmed Central PMCID: PMC6422517. Epub 2018/11/06. eng.
25. Guan H, Shang G, Cui Y, Liu J, Sun X, Cao W, et al. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1. Journal of cellular physiology. 2019 Jun;234(6):8998-9007. PubMed PMID: 30317613. Epub 2018/10/15. eng.
26. Li G, Liu K, Du X. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression. Yonsei medical journal. 2018 Mar;59(2):226-35. PubMed PMID: 29436190. Pubmed Central PMCID: PMC5823824. Epub 2018/02/13. eng.
27. Liu P, Li X, Guo X, Chen J, Li C, Chen M, et al. Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway. Cell proliferation. 2019 Jul;52(4):e12614. PubMed PMID: 30983072. Pubmed Central PMCID: PMC6668968. Epub 2019/04/16. eng.
28. Zhang T, Liu C, Huang S, Ma Y, Fang J, Chen Y. A Downmodulated MicroRNA Profiling in Patients with Gastric Cancer. Gastroenterology research and practice. 2017;2017:1526981. PubMed PMID: 28546810. Pubmed Central PMCID: PMC5436063. Epub 2017/05/27. eng.
29. Wang J, Zhang H, Zhou X, Wang T, Zhang J, Zhu W, et al. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma. Cancer biomarkers : section A of Disease markers. 2018;23(2):193-203. PubMed PMID: 30198863. Epub 2018/09/11. eng.
30. Wang Q, Wen YG, Li DP, Xia J, Zhou CZ, Yan DW, et al. Upregulated INHBA expression is associated with poor survival in gastric cancer. Medical oncology. 2012;29(1):77-83.
31. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R, et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell. 2003 Aug;14(8):3208-15. PubMed PMID: 12925757. Pubmed Central PMCID: PMC181561. Epub 2003/08/20. eng.
32. D'Errico M, de Rinaldis E, Blasi MF, Viti V, Falchetti M, Calcagnile A, et al. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. European journal of cancer. 2009 Feb;45(3):461-9. PubMed PMID: 19081245.
33. Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data using Real-Time Quantitative PCR. Methods. 2002;25(4):402-8.
34. Huszar D, Theoclitou ME, Skolnik J, Herbst R. Kinesin motor proteins as targets for cancer therapy. Cancer & Metastasis Reviews. 2009;28(1-2):197-208.
35. Lucanus AJ, Yip GW. Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics. Oncogene. 2018 Feb 15;37(7):833-8. PubMed PMID: 29059174.
36. Yang Z, Li C, Yan C, Li J, Yan M, Liu B, et al. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer. Biochimica et biophysica acta Molecular basis of disease. 2019 Jan;1865(1):181-92. PubMed PMID: 30404039.
37. Wang ZZ, Yang J, Jiang BH, Di JB, Gao P, Peng L, et al. KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer. International journal of oncology. 2018 Nov;53(5):1939-52. PubMed PMID: 30226594. Pubmed Central PMCID: 6192758.
38. Zhou J, Chen WR, Yang LC, Wang J, Sun JY, Zhang WW, et al. KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer. Cancer research and treatment : official journal of Korean Cancer Association. 2019 Jul;51(3):1207-21. PubMed PMID: 30590004. Pubmed Central PMCID: PMC6639218. Epub 2018/12/28. eng.
39. Li XL, Ji YM, Song R, Li XN, Guo LS. KIF23 Promotes Gastric Cancer by Stimulating Cell Proliferation. Disease markers. 2019;2019:9751923. PubMed PMID: 31007778. Pubmed Central PMCID: PMC6441499. Epub 2019/04/23. eng.
40. Kara M, Yumrutas O, Ozcan O, Celik OI, Bozgeyik E, Bozgeyik I, et al. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene. 2015 Aug 1;567(1):81-6. PubMed PMID: 25925209.
41. Zhang H, Liu A, Feng X, Tian L, Bo W, Wang H, et al. MiR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN. Progress in biophysics and molecular biology. 2019 Nov;148:65-72. PubMed PMID: 28941804.
42. Hangzhou, Wang, Xue-Tao, Li, Chun, Wu, et al. miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro. OncoTargets and therapy. 2015 Nov;8:3211-8. PubMed PMID: 26604788
43. Zhou K, Zhang C, Yao H, Zhang X, Zhou Y, Che Y, et al. Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132. Molecular cancer. 2018 Jul 27;17(1):105. PubMed PMID: 30053878. Pubmed Central PMCID: 6064054.
44. He L, Qu L, Wei L, Chen Y, Suo J. Reduction of miR‑132‑3p contributes to gastric cancer proliferation by targeting MUC13. Molecular medicine reports. 2017 May;15(5):3055-61. PubMed PMID: 28339011. Pubmed Central PMCID: PMC5428394. Epub 2017/03/25. eng.
45. Li G, Chong T, Yang J, Li H, Chen H. Kinesin Motor Protein KIFC1 Is a Target Protein of miR-338-3p and Is Associated With Poor Prognosis and Progression of Renal Cell Carcinoma. Oncology research. 2018 Dec 27;27(1):125-37. PubMed PMID: 29562961. Epub 2018/03/23. eng.
46. Wang B, Yu J, Sun Z, Luh F, Lin D, Shen Y, et al. Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer. Mol Carcinog. 2020 Aug;59(8):908-22. PubMed PMID: 32346924. Pubmed Central PMCID: PMC7384136. Epub 2020/04/30. eng.
47. Sheng N, Xu YZ, Xi QH, Jiang HY, Wang CY, Zhang Y, et al. Overexpression of KIF2A is Suppressed by miR-206 and Associated with Poor Prognosis in Ovarian Cancer. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2018;50(3):810-22. PubMed PMID: 30352438. Epub 2018/10/24. eng.
48. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annual review of cell and developmental biology. 2004;20:781-810. PubMed PMID: 15473860.
49. Talbot LJ, Bhattacharya SD, Kuo PC. Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. International journal of biochemistry and molecular biology. 2012;3(2):117-36. PubMed PMID: 22773954. Pubmed Central PMCID: 3388731.
50. Guo H, Zhang X, Chen Q, Bao Y, Dong C, Wang X. miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition. American journal of translational research. 2018;10(1):224-34. PubMed PMID: 29423007. Pubmed Central PMCID: PMC5801360. Epub 2018/02/10. eng.
51. You J, Li Y, Fang N, Liu B, Zu L, Chang R, et al. MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2. PloS one. 2014;9(3):e91827. PubMed PMID: 24626466. Pubmed Central PMCID: PMC3953608. Epub 2014/03/15. eng.
52. Zhao JL, Zhang L, Guo X, Wang JH, Zhou W, Liu M, et al. miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells. IUBMB life. 2015 May;67(5):380-94. PubMed PMID: 25988335. Epub 2015/05/20. eng.
53. Gu S, Liang H, Qi D, Mao L, Mao G, Qian L, et al. Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion. OncoTargets and therapy. 2018;11:3195-203. PubMed PMID: 29881293. Pubmed Central PMCID: 5985780.